{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:11:18Z","timestamp":1789096278863,"version":"build-2803163510"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T00:00:00Z","timestamp":1103673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Recent studies suggest that the <jats:italic>Helicobacter pylori<\/jats:italic> eradication rate in patients with non\u2010ulcer dyspepsia is lower when compared to patients with peptic ulcer diseases.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002The aim of this study was to study the efficacy of triple therapy for <jats:italic>H. pylori<\/jats:italic> infection in patients with duodenal ulcer vs. patients with non\u2010ulcer dyspepsia.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002A total of 582 Chinese patients with proven <jats:italic>H. pylori<\/jats:italic> infection were recruited to receive: omeprazole 20\u2003mg, amoxicillin 1000\u2003mg and clarithromycin 500\u2003mg all given twice daily for 7\u2003days (OCA regime). Endoscopy with rapid urease test, histology and culture were performed before treatment. Post\u2010treatment <jats:italic>H. pylori<\/jats:italic> status was determined by <jats:sup>13<\/jats:sup>C\u2010urea breath test. Metronidazole, clarithromycin and amoxicillin resistance was defined as minimum inhibitory concentration (MIC) of &gt;8\u2003<jats:italic>\u03bc<\/jats:italic>g\/mL, &gt;1\u2003<jats:italic>\u03bc<\/jats:italic>g\/mL and &gt;1\u2003<jats:italic>\u03bc<\/jats:italic>g\/mL, respectively.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002A significantly higher (intention\u2010to\u2010treat\/per\u2010protocol) eradication rate was found in patients with duodenal ulcer than those with non\u2010ulcer dyspepsia (91\/94% vs. 84\/88% respectively, <jats:italic>P<\/jats:italic>\u2003=\u20030.011 and <jats:italic>P<\/jats:italic>\u2003=\u20030.016). Clarithromycin resistance rate was higher in patients with non\u2010ulcer dyspepsia than those with duodenal ulcer (14% vs. 6%, <jats:italic>P<\/jats:italic>\u2003=\u20030.015). Clarithromycin resistance (40% vs. 5%, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001, OR 12, 95% CI: 5.7\u201324.3) and the diagnosis of non\u2010ulcer dyspepsia (91% vs. 84%, <jats:italic>P<\/jats:italic>\u2003=\u20030.011, OR 2.0, 95% CI: 1.2\u20133.3) significantly affected the success of <jats:italic>H. pylori<\/jats:italic> eradication.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> :\u2002Clarithromycin resistance accounts for the significantly lower and suboptimal <jats:italic>H. pylori<\/jats:italic> eradication rate of OCA regimen in Chinese patients with non\u2010ulcer dyspepsia compared to those with duodenal ulcer.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02283.x","type":"journal-article","created":{"date-parts":[[2005,1,10]],"date-time":"2005-01-10T09:29:59Z","timestamp":1105349399000},"page":"73-81","source":"Crossref","is-referenced-by-count":15,"title":["Standard treatment for <i>Helicobacter pylori<\/i> infection is suboptimal in non\u2010ulcer dyspepsia compared with duodenal ulcer in Chinese"],"prefix":"10.1111","volume":"21","author":[{"given":"W. M.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. D.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. H.\u2010X.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. C.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H. C.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. C.\u2010Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,12,22]]},"reference":[{"key":"e_1_2_18_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00537.x"},{"key":"e_1_2_18_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01169.x"},{"key":"e_1_2_18_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409094890"},{"key":"e_1_2_18_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.3.321"},{"key":"e_1_2_18_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200111000-00007"},{"key":"e_1_2_18_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00895.x"},{"key":"e_1_2_18_8_2","first-page":"A84","article-title":"Duodenal ulcer and functional dyspepsia: different susceptibility of Helicobacter pylori to eradicating therapy","volume":"112","author":"Catalano F","year":"1997","journal-title":"Gastroenterology"},{"issue":"1","key":"e_1_2_18_9_2","first-page":"A91","article-title":"Outcome of omeprazole\u2010based dual and triple therapy for Helicobacter pylori eradication: do gastroduodenal disease and age play a role","volume":"41","author":"Pieramico O","year":"1997","journal-title":"Gut"},{"issue":"2","key":"e_1_2_18_10_2","first-page":"A85","article-title":"Efficacy of PPI\u2010triple therapy in H. pylori (Hp) positive patients with ulcer disease versus patients with non\u2010ulcer dyspepsia","volume":"43","author":"Houben MHMG","year":"1998","journal-title":"Gut"},{"issue":"2","key":"e_1_2_18_11_2","first-page":"A92","article-title":"Different Helicobacter pylori eradication rates between non\u2010ulcer dyspepsia and peptic ulcer patients","volume":"43","author":"Zullo A","year":"1998","journal-title":"Gut"},{"key":"e_1_2_18_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)80577-5"},{"issue":"5","key":"e_1_2_18_13_2","first-page":"A270","article-title":"Does the efficacy of eradication treatment with OCA\u20107 decrease in non\u2010ulcer gastroduodenal disease","volume":"45","author":"Borda F","year":"1999","journal-title":"Gut"},{"issue":"1","key":"e_1_2_18_14_2","first-page":"A104","article-title":"Is PPI\u2010triple therapy of greater efficacy in peptic ulcer than in non\u2010ulcer dyspeptic patients","volume":"47","author":"Katicic M","year":"2000","journal-title":"Gut"},{"issue":"2","key":"e_1_2_18_15_2","first-page":"A94","article-title":"Helicobacter pylori eradication rates in non\u2010ulcer dyspepsia (NUD) and duodenal ulcer (DU) patients","volume":"49","author":"De Francesco V","year":"2001","journal-title":"Gut"},{"key":"e_1_2_18_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/377206"},{"key":"e_1_2_18_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00795.x"},{"key":"e_1_2_18_18_2","volume-title":"The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment","author":"Drossman DA","year":"1994"},{"key":"e_1_2_18_19_2","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing and Approved Standard M7\u2010A5. Informational Supplement M100\u2010S10.22","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"e_1_2_18_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00843.x"},{"key":"e_1_2_18_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01223.x"},{"key":"e_1_2_18_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01459.x"},{"issue":"3","key":"e_1_2_18_23_2","first-page":"413","article-title":"Are one\u2010week anti\u2010H. pylori treatments more effective in patients with peptic ulcer disease (PUD) than in those with non\u2010ulcer dyspepsia (NUD)? A meta\u2010analysis","volume":"59","author":"Huang JQ","year":"1998","journal-title":"Digestion"},{"key":"e_1_2_18_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199901000-00005"},{"key":"e_1_2_18_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01396.x"},{"key":"e_1_2_18_26_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1007.030612"},{"key":"e_1_2_18_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.5.1978-1980.2001"},{"key":"e_1_2_18_28_2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1128\/jcm.35.6.1344-1347.1997","article-title":"Equally high prevalences of infection with cagA\u2010positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis\u2010associated dyspepsia","volume":"35","author":"Pan ZJ","year":"1997","journal-title":"J Clin Microbiol"},{"key":"e_1_2_18_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.1999.01892.x"},{"key":"e_1_2_18_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051925"},{"key":"e_1_2_18_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.02944.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02283.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02283.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:14:07Z","timestamp":1697242447000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02283.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02283.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02283.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,22]]}}}